These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21527305)

  • 1. Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective.
    Tavares F; Delaigle A; Slavin D; Bauchau V; Fries L; Seifert H
    Vaccine; 2011 Aug; 29(37):6402-7. PubMed ID: 21527305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.
    Gagnon R; Primeau MN; Des Roches A; Lemire C; Kagan R; Carr S; Ouakki M; Benoît M; De Serres G;
    J Allergy Clin Immunol; 2010 Aug; 126(2):317-23. PubMed ID: 20579720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
    Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
    Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
    Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
    Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada.
    Rouleau I; De Serres G; Skowronski DM; Drolet JP; Lemire C; Toth E; Landry M
    Vaccine; 2014 Jun; 32(28):3480-7. PubMed ID: 24793951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review.
    Isai A; Durand J; Le Meur S; Hidalgo-Simon A; Kurz X
    Vaccine; 2012 Nov; 30(49):7123-9. PubMed ID: 23022149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
    Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
    Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
    Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine safety.
    Labadie J
    Int J Risk Saf Med; 2011; 23(2):113-5. PubMed ID: 21673419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
    Choe YJ; Cho H; Bae GR; Lee JK
    Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring adverse events of vaccines against Mexican flu.
    van Puijenbroek EP; van Grootheest AC
    Int J Risk Saf Med; 2011; 23(2):81-7. PubMed ID: 21673415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.
    Mahmud S; Hammond G; Elliott L; Hilderman T; Kurbis C; Caetano P; Van Caeseele P; Kettner J; Dawood M
    Vaccine; 2011 Oct; 29(45):7975-81. PubMed ID: 21884747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines against influenza A (H1N1) pandemic.
    Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?
    McNeil MM; Arana J; Stewart B; Hartshorn M; Hrncir D; Wang H; Lamias M; Locke M; Stamper J; Tokars JI; Engler RJ
    Vaccine; 2012 Mar; 30(14):2421-6. PubMed ID: 22310205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
    Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
    Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of fatal adverse events after H1N1 influenza vaccination.
    Nakada H; Narimatsu H; Tsubokura M; Murashige N; Matsumura T; Kodama Y; Kishi Y; Kami M
    Clin Infect Dis; 2010 Jun; 50(11):1548-9. PubMed ID: 20433361
    [No Abstract]   [Full Text] [Related]  

  • 19. Network analysis of possible anaphylaxis cases reported to the US vaccine adverse event reporting system after H1N1 influenza vaccine.
    Botsis T; Ball R
    Stud Health Technol Inform; 2011; 169():564-8. PubMed ID: 21893812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
    Härmark L; van Hunsel F; Hak E; van Grootheest K
    Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.